(September 26, 2016, 1:16 PM EDT) -- ALEXANDRIA, Va. — A petition by Teva Pharmaceuticals USA Inc. for inter partes review of 31 claims of a patent that claims compositions useful in the treatment of diabetes was granted...
Patent Board Grants Petition, Consolidates Drug Patent Challenges
To view the full article, register now.
Try for FREE for fourteen days
Already a subscriber? Click here to login